Last updated on February 2019

A Study to Evaluate the Efficacy and Safety of Adjunctive Brivaracetam in Asian Subjects (>=16 to 80 Years of Age) With Epilepsy


Brief description of study

The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) compared to placebo (PBO) as adjunctive treatment in Asian subjects (>=16 to 80 years of age) with partial seizures with or without secondary generalization despite current treatment with 1 or 2 concomitant antiepileptic drugs (AEDs) and to assess the safety and tolerability of BRV in subjects >= 16 years to 80 years of age.

Clinical Study Identifier: NCT03083665

Contact Investigators or Research Sites near you

Start Over

UCB Cares

Ep0083 116
Asaka, Japan
  Connect »

UCB Cares

Ep0083 122
Hachinohe, Japan
  Connect »

UCB Cares

Ep0083 111
Hamamatsu, Japan
  Connect »

UCB Cares

Ep0083 110
Hiroshima, Japan
  Connect »

UCB Cares

Ep0083 121
Itami, Japan
  Connect »

UCB Cares

Ep0083 125
Iwanuma, Japan
  Connect »

UCB Cares

Ep0083 102
Kagoshima, Japan
  Connect »

UCB Cares

Ep0083 119
Kobe, Japan
  Connect »

UCB Cares

Ep0083 123
Kodaira, Japan
  Connect »

UCB Cares

Ep0083 115
Kokubunji, Japan
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.